Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure

American Journal of Cardiology

Volumn 82, Issue 4, 1998, Pages 465-469

  Luzier, Aileen Bown ^a   Forrest, Alan ^a   Adelman, Martin ^a   Hawari, Feras I ^a   Schentag, Jerome J ^a   Izzo Jr , Joseph L ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Millard Fillmore Gates Circle Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOTONIC AGENTS; COHORT STUDIES; DIGOXIN; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PATIENT READMISSION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0031843983     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00361-0     Document Type: Article

References (14)

1. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity is patients with heart failure. N Engl J Med 1996;336:525-533.
2. Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voohees L, Gourley LA, Jolly MK. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med 1993;329:1-7.
3. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327: 685-691.
4. The CONSENSUS Trial Study Group. Tolerability of enalapril in congestive heart failure. The Cooperative North Scandinavian Enalapril Study Group (CONSENSUS). Am J Cardiol 1988;62 Suppl A:67A-72A.
5. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Gettman EM, Goldman S, Flaker GC. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-677.
6. Konstam MA, Dracup K, Baker DW, Bottorff MB, Brooks NH, Darcey RA, Dunbar SB, Jackson AB, Jessup M, Johnson JC, Jones RH, Luchi RJ, Massie BM, Pitt B, Rose EA, Rubin LJ, Wright RF, Hadhorn DC. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. Clinical practice guideline, no. 11. Rockville, Md.: Agency for Health Care Policy and Research, 1994. (AHCPR publication no. 94-0612.)
7. Philbin EF, Andreou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77:832-838.
8. Food and Drug Administration. Data on file, March 1992. Washington, DC: FDA, 1992.
9. Vince JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990;38:1290-1295.
10. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195.
11. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
12. Wilkinson, L. SYSTAT: The System for Statisitics. Evanston, IL: SYSTAT, Inc., 1990.
13. D'Argenio DZ, Schumitzky A. ADAPT II User's guide. Biomedical Simulations Resource, University of Southern California, Los Angeles, 1990:3-9.
14. Akaike H. 1979. A Bayesian Extension of the Minimum AIC Procedure of Auto regressive Model Fitting. Biometrika 66:237-242.